| scholarly article | Q13442814 |
| P2093 | author name string | Benjamin L Musher | |
| Susan Hilsenbeck | |||
| Eunji Jo | |||
| Aaron P Thrift | |||
| Preeti Prakash | |||
| Kelsey Lau-Min | |||
| P2860 | cites work | Increase in incidence of colorectal cancer among young men and women in the United States | Q84022118 |
| Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer | Q28240089 | ||
| Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer | Q28298328 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status | Q29619648 | ||
| Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study | Q29619653 | ||
| A black-white comparison of the quality of stage-specific colon cancer treatment | Q33625791 | ||
| Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities | Q33803097 | ||
| Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves | Q34148380 | ||
| FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial | Q34663697 | ||
| Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer | Q35249066 | ||
| Adherence to stage-specific treatment guidelines for patients with colon cancer | Q35925153 | ||
| A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results | Q36246590 | ||
| Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. | Q36336606 | ||
| Disparities in timeliness of care for U.S. Medicare patients diagnosed with cancer | Q36416253 | ||
| Colorectal cancer model of health disparities: understanding mortality differences in minority populations | Q36472206 | ||
| Racial disparity in death from colorectal cancer: does vitamin D deficiency contribute? | Q36745243 | ||
| Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study | Q36828417 | ||
| Racial/Ethnic Disparities in Survival Among Patients With Young-Onset Colorectal Cancer | Q37130130 | ||
| Examining potential colorectal cancer care disparities in the Veterans Affairs health care system | Q37195246 | ||
| Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis | Q37304231 | ||
| Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial. | Q37325078 | ||
| Colorectal cancer disparities: issues, controversies and solutions | Q37578721 | ||
| Comparison of survival outcomes among cancer patients treated in and out of clinical trials | Q37696455 | ||
| Racial/ethnic disparities in human DNA methylation | Q38228654 | ||
| Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial. | Q38375269 | ||
| Rising Incidence of Colorectal Cancer Among Young Hispanics in Texas | Q38783758 | ||
| Racial disparities in colon cancer survival: a matched cohort study | Q41690895 | ||
| Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. | Q44156436 | ||
| Racial disparity in colorectal cancer: the role of equal treatment | Q45153737 | ||
| Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002). | Q46236488 | ||
| Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer | Q46742453 | ||
| Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer | Q47582770 | ||
| Association of area sociodemographic characteristics and capacity for treatment with disparities in colorectal cancer care and mortality. | Q50112556 | ||
| Treatment of metastatic colon cancer: "the times they are A-changing". | Q51030597 | ||
| Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study | Q57152185 | ||
| Racial disparities in stage-specific colorectal cancer mortality: 1960-2005 | Q57272317 | ||
| Effect of race on colon cancer treatment and outcomes in the Department of Defense healthcare system | Q82242361 | ||
| P921 | main subject | colorectal cancer | Q188874 |
| metastatic colon cancer | Q108566365 | ||
| P577 | publication date | 2020-01-02 | |
| P1433 | published in | Clinical Colorectal Cancer | Q332277 |
| P1476 | title | Outcomes Among Minority Patients With Metastatic Colorectal Cancer in a Safety-net Health Care System |
Search more.